|
US3749088A
(en)
|
1971-06-23 |
1973-07-31 |
W Kohlmann |
Surgical retractor device
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
WO1993007883A1
(en)
|
1991-10-24 |
1993-04-29 |
Isis Pharmaceuticals, Inc. |
Derivatized oligonucleotides having improved uptake and other properties
|
|
WO1998021366A1
(en)
|
1996-11-13 |
1998-05-22 |
Qbi Enterprises, Ltd. |
Gene identification method
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
AU9063398A
(en)
|
1997-09-12 |
1999-04-05 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US6139493A
(en)
*
|
1998-07-08 |
2000-10-31 |
Koros; Tibor B. |
Retractor with adjustable length blades and light pipe guides
|
|
CZ296576B6
(cs)
|
1999-02-12 |
2006-04-12 |
Sankyo Company Limited |
Nukleosidový analog a oligonukleotidový analog a farmaceutický prostredek, sonda a primer s jeho obsahem
|
|
EP1178999B1
(en)
|
1999-05-04 |
2007-03-14 |
Santaris Pharma A/S |
L-ribo-lna analogues
|
|
US6617442B1
(en)
|
1999-09-30 |
2003-09-09 |
Isis Pharmaceuticals, Inc. |
Human Rnase H1 and oligonucleotide compositions thereof
|
|
GB2375172A
(en)
|
2000-02-07 |
2002-11-06 |
Quark Biotech Inc |
Fas pathway genes
|
|
WO2002060330A1
(en)
*
|
2001-01-29 |
2002-08-08 |
Stephen Ritland |
Retractor and method for spinal pedicle screw placement
|
|
WO2005060667A2
(en)
|
2003-12-19 |
2005-07-07 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
|
WO2003016475A2
(en)
|
2001-08-14 |
2003-02-27 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
|
AU2002351828A1
(en)
|
2001-11-05 |
2003-05-19 |
Deutsches Krebsforschungszentrum |
Novel genetic markers for leukemias
|
|
US20030157082A1
(en)
|
2002-01-31 |
2003-08-21 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cancer using 140, 1470, 1686, 2089, 2427, 3702, 5891, 6428, 7181, 7660, 25641, 69583, 49863, 8897, 1682, 17667, 9235, 3703, 14171, 10359, 1660, 1450, 18894, 2088, 32427, 2160, 9252, 9389, 1642, 85269, 10297, 1584, 9525, 14124, 4469, 8990, 2100, 9288, 64698, 10480,20893, 33230,1586, 9943, 16334, 68862, 9011, 14031, 6178, 21225, 1420, 32236, 2099, 2150, 26583, 2784, 8941, 9811, 27444, 50566 or 66428 molecules
|
|
US20040101855A1
(en)
*
|
2002-11-22 |
2004-05-27 |
Isis Pharmaceuticals Inc. |
Modulation of PPAR binding protein expression
|
|
US9259144B2
(en)
|
2002-07-11 |
2016-02-16 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
WO2004012817A2
(en)
|
2002-07-31 |
2004-02-12 |
Kylix B.V. |
Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
|
|
JP2006513701A
(ja)
|
2002-10-11 |
2006-04-27 |
アーラム バイオシステムズ インコーポレイテッド |
核酸ベースのシグナルトランスデューサーを含む立体構造的に敏感なプローブを有する標的検出システム
|
|
US7850608B2
(en)
|
2002-10-25 |
2010-12-14 |
K2M, Inc. |
Minimal incision maximal access MIS spine instrumentation and method
|
|
US9045518B2
(en)
*
|
2002-11-18 |
2015-06-02 |
Santaris Pharma A/S |
Amino-LNA, thio-LNA and alpha-L-oxy-LN
|
|
US7691057B2
(en)
|
2003-01-16 |
2010-04-06 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
US7256200B2
(en)
|
2003-02-10 |
2007-08-14 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Method and composition for potentiating an oplate analgesic
|
|
US7819801B2
(en)
|
2003-02-27 |
2010-10-26 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
US20050085436A1
(en)
|
2003-07-08 |
2005-04-21 |
Hao Li |
Method to treat conditions associated with insulin signalling dysregulation
|
|
US7481766B2
(en)
|
2003-08-14 |
2009-01-27 |
Synthes (U.S.A.) |
Multiple-blade retractor
|
|
US20050137461A1
(en)
*
|
2003-12-18 |
2005-06-23 |
Depuy Spine, Inc. |
Telescoping blade assembly and instruments for adjusting an adjustable blade
|
|
US7374927B2
(en)
*
|
2004-05-03 |
2008-05-20 |
Affymetrix, Inc. |
Methods of analysis of degraded nucleic acid samples
|
|
US9622732B2
(en)
*
|
2004-10-08 |
2017-04-18 |
Nuvasive, Inc. |
Surgical access system and related methods
|
|
JP2006223228A
(ja)
|
2005-02-18 |
2006-08-31 |
Dainippon Sumitomo Pharma Co Ltd |
自己免疫疾患治療剤のスクリーニング方法
|
|
US20060287584A1
(en)
*
|
2005-06-16 |
2006-12-21 |
Javier Garcia-Bengochia |
Surgical retractor extensions
|
|
CN1904900A
(zh)
*
|
2005-07-28 |
2007-01-31 |
中国科学院生物物理研究所 |
人类的内源性siRNA序列及其应用和筛选方法
|
|
WO2007031091A2
(en)
|
2005-09-15 |
2007-03-22 |
Santaris Pharma A/S |
Rna antagonist compounds for the modulation of p21 ras expression
|
|
WO2007059533A2
(en)
*
|
2005-11-18 |
2007-05-24 |
Myogen, Inc. |
Uses for camki i and hdacs in the treatment of heart conditions
|
|
JP5342881B2
(ja)
|
2006-01-27 |
2013-11-13 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
６−修飾された二環式核酸類似体
|
|
US20090156540A1
(en)
*
|
2006-03-07 |
2009-06-18 |
Mckenna Katherine |
Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same
|
|
EP2023940B1
(en)
|
2006-05-05 |
2011-06-22 |
Isis Pharmaceuticals, Inc. |
Compounds and methods for modulating expression of sglt2
|
|
US7666854B2
(en)
|
2006-05-11 |
2010-02-23 |
Isis Pharmaceuticals, Inc. |
Bis-modified bicyclic nucleic acid analogs
|
|
AU2007249349B2
(en)
|
2006-05-11 |
2012-03-08 |
Isis Pharmaceuticals, Inc. |
5'-Modified bicyclic nucleic acid analogs
|
|
WO2008020435A2
(en)
|
2006-08-15 |
2008-02-21 |
Quark Pharmaceuticals, Inc |
Compositions and methods for treatment of mood disorders
|
|
ES2534430T3
(es)
|
2006-08-28 |
2015-04-22 |
The University Of Western Australia |
Método de modulación de la expresión del receptor del factor de crecimiento epidérmico (EGFR) que implica miARN
|
|
GB0617222D0
(en)
|
2006-08-31 |
2006-10-11 |
Vereniging Het Nl Kanker I |
Antibiotics
|
|
US8062217B2
(en)
*
|
2007-01-26 |
2011-11-22 |
Theken Spine, Llc |
Surgical retractor with removable blades and method of use
|
|
WO2008113832A2
(en)
|
2007-03-22 |
2008-09-25 |
Santaris Pharma A/S |
SHORT RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF TARGET mRNA
|
|
EP2170917B1
(en)
|
2007-05-30 |
2012-06-27 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
|
EP2173760B2
(en)
|
2007-06-08 |
2015-11-04 |
Isis Pharmaceuticals, Inc. |
Carbocyclic bicyclic nucleic acid analogs
|
|
WO2008152636A2
(en)
*
|
2007-06-15 |
2008-12-18 |
Quark Pharmaceuticals, Inc. |
Compositions and methods for inhibiting nadph oxidase expression
|
|
CA2692579C
(en)
|
2007-07-05 |
2016-05-03 |
Isis Pharmaceuticals, Inc. |
6-disubstituted bicyclic nucleic acid analogs
|
|
DE202007012284U1
(de)
|
2007-09-01 |
2007-10-25 |
Aesculap Ag & Co. Kg |
Chirurgischer Retraktor
|
|
US8546556B2
(en)
|
2007-11-21 |
2013-10-01 |
Isis Pharmaceuticals, Inc |
Carbocyclic alpha-L-bicyclic nucleic acid analogs
|
|
US8841423B2
(en)
|
2008-04-28 |
2014-09-23 |
University Of Iowa Research Foundation |
Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II
|
|
WO2010036698A1
(en)
|
2008-09-24 |
2010-04-01 |
Isis Pharmaceuticals, Inc. |
Substituted alpha-l-bicyclic nucleosides
|
|
EP2177615A1
(en)
|
2008-10-10 |
2010-04-21 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Method for a genome wide identification of expression regulatory sequences and use of genes and molecules derived thereof for the diagnosis and therapy of metabolic and/or tumorous diseases
|
|
US8226554B2
(en)
|
2008-10-30 |
2012-07-24 |
Warsaw Orthopedic, Inc. |
Retractor assemblies for surgery in a patient
|
|
WO2010120969A1
(en)
|
2009-04-15 |
2010-10-21 |
Board Of Regents, The University Of Texas System |
Targeting of the mir-30 family and let-7 family as a treatment for heart disease
|
|
ES2555057T3
(es)
*
|
2009-06-12 |
2015-12-28 |
Roche Innovation Center Copenhagen A/S |
Nuevos potentes compuestos antisentido anti-ApoB
|
|
US8563528B2
(en)
*
|
2009-07-21 |
2013-10-22 |
Santaris Pharma A/S |
Antisense oligomers targeting PCSK9
|
|
EP2462153B1
(en)
|
2009-08-06 |
2015-07-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexose nucleic acid analogs
|
|
EP2490699A1
(en)
|
2009-10-20 |
2012-08-29 |
Santaris Pharma A/S |
Oral delivery of therapeutically effective lna oligonucleotides
|
|
US9737288B2
(en)
*
|
2010-03-11 |
2017-08-22 |
Globus Medical, Inc |
Tissue retractor and methods of use
|
|
EP2580228B1
(en)
|
2010-06-08 |
2016-03-23 |
Ionis Pharmaceuticals, Inc. |
Substituted 2'-amino and 2'-thio-bicyclic nucleosides and oligomeric compounds prepared therefrom
|
|
WO2012024255A2
(en)
|
2010-08-16 |
2012-02-23 |
Duke University |
Camkk-beta as a target for treating cancer
|
|
EP3778896A1
(en)
|
2011-08-09 |
2021-02-17 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for inhibiting the growth and/or proliferation of myc-driven tumor cells
|
|
EP3453761A1
(en)
|
2011-08-29 |
2019-03-13 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
WO2013033436A1
(en)
*
|
2011-09-01 |
2013-03-07 |
University Of Iowa Research Foundation |
Oligonucleotide-based probes for detection of bacterial nucleases
|
|
CA2857374A1
(en)
|
2011-09-02 |
2013-03-07 |
The Trustees Of Columbia University In The City Of New York |
Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity
|
|
CN104136451A
(zh)
|
2011-09-07 |
2014-11-05 |
玛瑞纳生物技术有限公司 |
具有构象限制的单体的核酸化合物的合成和用途
|
|
WO2013151999A1
(en)
|
2012-04-02 |
2013-10-10 |
President And Fellows Of Harvard College |
Cancer treatment and immune system regulation through fat10 pathway inhibition
|
|
EP2850092B1
(en)
|
2012-04-09 |
2017-03-01 |
Ionis Pharmaceuticals, Inc. |
Tricyclic nucleic acid analogs
|
|
US20150141320A1
(en)
*
|
2012-05-16 |
2015-05-21 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating gene expression
|
|
US10077443B2
(en)
|
2012-11-15 |
2018-09-18 |
Roche Innovation Center Copenhagen A/S |
Oligonucleotide conjugates
|
|
WO2014077693A1
(en)
|
2012-11-16 |
2014-05-22 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Means and methods for reducing an effect of aging in a mammalian cell
|
|
AU2014225889B2
(en)
|
2013-03-06 |
2018-12-06 |
The Johns Hopkins University |
CaMKII inhibitors and uses thereof
|
|
DK2991656T3
(da)
|
2013-05-01 |
2020-03-23 |
Ionis Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til modulering af apolipoprotein c-iii-ekspression
|
|
US20140329755A1
(en)
|
2013-05-01 |
2014-11-06 |
Gilead Sciences, Inc. |
Combination therapy for the treatment of arrhythmias or heart failure
|
|
ES2770667T3
(es)
|
2013-06-27 |
2020-07-02 |
Roche Innovation Ct Copenhagen As |
Oligómeros antisentido y conjugados que se dirigen a PCSK9
|
|
WO2016037106A1
(en)
|
2014-09-05 |
2016-03-10 |
Allosteros Therapeutics, Inc |
CaMKII INHIBITORS AND USES THEREOF
|
|
PL3265563T3
(pl)
|
2015-02-02 |
2021-09-13 |
Meiragtx Uk Ii Limited |
Regulacja ekspresji genów poprzez modulację alternatywnego splicingu za pośrednictwem aptamerów
|
|
EP3286318A2
(en)
|
2015-04-22 |
2018-02-28 |
Mina Therapeutics Limited |
Sarna compositions and methods of use
|
|
US10494632B2
(en)
*
|
2015-07-10 |
2019-12-03 |
Alnylam Pharmaceuticals, Inc. |
Insulin-like growth factor binding protein, acid labile subunit (IGFALS) compositions and methods of use thereof
|
|
US20210052631A1
(en)
|
2015-09-25 |
2021-02-25 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
EP3353306A4
(en)
|
2015-09-25 |
2019-06-05 |
Ionis Pharmaceuticals, Inc. |
Conjugated antisense compounds and their use
|
|
CA3005090A1
(en)
*
|
2015-12-14 |
2017-06-22 |
Cold Spring Harbor Laboratory |
Compositions and methods for treatment of liver diseases
|
|
AU2017292173B2
(en)
*
|
2016-07-06 |
2022-01-13 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of pain related disorders
|
|
SMT202400091T1
(it)
|
2016-08-03 |
2024-05-14 |
Meiragtx Uk Ii Ltd |
Screening ad alta produzione basato su cellule per 5 aptameri
|
|
WO2019049148A1
(en)
|
2017-09-10 |
2019-03-14 |
Carmel Haifa University Economic Corporation Ltd. |
METHOD OF TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER
|
|
US10717981B2
(en)
|
2018-01-18 |
2020-07-21 |
Advanced ReGen Medical Technologies, LLC |
Therapeutic compositions and methods of making and using the same
|
|
KR20200140805A
(ko)
|
2018-02-21 |
2020-12-16 |
브리스톨-마이어스 스큅 컴퍼니 |
Camk2d 안티센스 올리고뉴클레오티드 및 그의 용도
|
|
WO2019217459A1
(en)
|
2018-05-07 |
2019-11-14 |
Alnylam Pharmaceuticals, Inc. |
Extrahepatic delivery
|